IS EU ORPHAN MEDICINE STATUS WORKING? A RETROSPECTIVE ANALYSIS OF ORPHAN DRUG REIMBURSEMENT IN ENGLAND

被引：0
|
作者：
Coyle, S. [1 ]
Mumford, J. [1 ]
Roberts, G. [2 ]
机构：
[1] Initiate Consultancy, London, England
[2] Initiate Consultancy, Northants, Nth, England
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRO81
引用
收藏
页码：S704 / S704
页数：1
相关论文
共 50 条
  • [1] Orphan Drug Pricing and Reimbursement Policies Lacking in EU
    不详
    PHARMACEUTICAL MEDICINE, 2018, 32 (04) : 297 - 298
  • [2] ORPHAN DRUG REIMBURSEMENT IN ENGLAND AND IMPLICATIONS FOR PATIENT ACCESS
    Walker, S.
    Lilley, H.
    Payne, R.
    Fountain, D.
    VALUE IN HEALTH, 2019, 22 : S859 - S859
  • [3] CHANGING LANDSCAPE OF ORPHAN DRUG REIMBURSEMENT - EVIDENCE FROM EU-4 AND ENGLAND
    Foxon, G.
    Tokarska, J.
    Debevec, D.
    Guillot, M.
    Lizan, L.
    Prada, M.
    Vollmer, L.
    VALUE IN HEALTH, 2022, 25 (12) : S235 - S235
  • [4] ASSESSING THE INFLUENCE OF THE ORPHAN DRUG STATUS ON MEDICINE PRICES IN THE EU4+UK
    Perez, A.
    Gas, N.
    Rives, V
    Parlato, G.
    Gaddam, K.
    Vialard, L.
    VALUE IN HEALTH, 2022, 25 (12) : S257 - S257
  • [5] Impact of the EU Orphan Drug Regulation on the Development of Orphan Drug: A 15-Year Analysis
    Pan, Irene
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 397 - 398
  • [6] Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU
    Joppi, Roberta
    Bertele', Vittorio
    Garattini, Silvio
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (04) : 1009 - 1024
  • [7] Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU
    Roberta Joppi
    Vittorio Bertele’
    Silvio Garattini
    European Journal of Clinical Pharmacology, 2013, 69 : 1009 - 1024
  • [8] TIME FOR REIMBURSEMENT FOR ORPHAN DRUGS IN EU5
    Prada, M.
    Berard, I
    Walzer, S.
    Darba, J.
    Greenwood, B.
    VALUE IN HEALTH, 2018, 21 : S264 - S264
  • [9] SOLUTIONS TO THE COMPARATOR QUESTION IN THE ABSENCE OF LICENSED COMPARATORS? A RETROSPECTIVE ANALYSIS OF ORPHAN DRUG AND GENE THERAPY REIMBURSEMENT IN EU5 MARKETS
    Mumford, A.
    English, B.
    Sopena, L.
    Munetsi, R.
    VALUE IN HEALTH, 2020, 23 : S671 - S672
  • [10] A COMPARATIVE ANALYSIS OF THE RELATIONSHIP BETWEEN ORPHAN DRUG STATUS AND REIMBURSEMENT STATUS IN IRELAND, SWEDEN, FRANCE, AND CANADA IN 2022
    Lyttle, S. J.
    Greenwood, M.
    Roberts, G.
    Mumford, A.
    VALUE IN HEALTH, 2023, 26 (06) : S228 - S228
12345